Board Director – Audit Committee & Capital Markets

Independent Board Director | SEC & Nasdaq Readiness | Institutional Financing
Aphios Corporation | Job Code: APH-2608
Help guide an innovative biotechnology company through its next phase of growth, institutional financing and public-market readiness.
Aphios Corporation is seeking an accomplished, independent Board Director with substantial experience in financial oversight, Audit Committee responsibilities and capital markets to join its expanding Board of Directors.
Aphios is a Phase 3-ready, platform biotechnology company advancing a diversified pipeline of therapeutics addressing significant unmet medical needs in oncology supportive care, neuroscience, addiction and other therapeutic areas.
With more than 85 issued patents, over $20 million in NIH grant funding and more than $50 million invested, Aphios is building upon three decades of scientific innovation and technology development as it prepares for institutional financing and the public markets.
The Opportunity
This is an opportunity for an experienced financial or capital-markets leader to help shape the governance, financing strategy and public-company infrastructure of an innovation-driven biotechnology enterprise.
The successful candidate will provide Board-level guidance in:
Audit Committee Leadership: Financial oversight, external audit, financial reporting, internal controls and enterprise risk management.
SEC & Nasdaq Readiness: Public-company governance, regulatory reporting requirements and preparation for a potential U.S. public-market listing.
Capital Markets: Institutional financing, investment banking, capital formation and public-market transactions.
Strategic Financial Oversight: Capital allocation, financial discipline, investor engagement and long-term value creation.
Corporate Governance: Independent Board oversight, fiduciary responsibilities and development of effective governance practices.
Ideal Candidate Profile
We welcome expressions of interest from accomplished professionals with backgrounds such as:
Current or former public-company CFOs, Chief Accounting Officers or senior financial executives.
Current or former public-company Audit Committee Chairs or members.
Senior investment banking, capital-markets or institutional investment professionals with relevant financial oversight expertise.
Biotechnology, pharmaceutical or healthcare executives experienced in public-company governance and financing.
Experienced independent directors who have helped companies navigate IPOs, direct listings or other public-market transitions.
Preferred Qualifications
Demonstrated financial literacy and expertise appropriate for public-company Audit Committee service.
Familiarity with SEC reporting, financial controls, auditor oversight and applicable Nasdaq governance requirements.
Experience with institutional capital formation or public-market transactions.
Strong independent judgment, financial integrity and strategic perspective.
Life sciences or healthcare industry experience preferred.
Candidates qualified to serve as an Audit Committee Financial Expert under applicable SEC standards are particularly encouraged to apply.
Why Aphios?
Aphios is at an important corporate inflection point, bringing together:
A Phase 3-ready lead therapeutic program.
A diversified clinical and preclinical development pipeline.
Proprietary drug-development and nanoparticle-delivery technologies.
An extensive intellectual property portfolio.
A strategy combining strategic partnerships, institutional financing and potential public-market access.
The selected Director will help strengthen financial governance, support capital-market readiness and contribute to the next phase of Aphios' development.
Board Compensation
Equity-based compensation, designed to align Board participation with long-term shareholder value creation. No cash compensation is currently offered.
Express Your Interest
Qualified candidates are invited to submit a résumé or professional biography, together with a brief statement of relevant Board, Audit Committee and capital-markets experience.
Reference: APH-2608 – Board Director, Audit Committee & Capital Markets
Email: mail@aphios.com
Website: www.aphios.com
Aphios Corporation
Inspired by Nature, Enabled by Science®
#BoardOfDirectors #IndependentDirector #AuditCommittee #CapitalMarkets #CorporateGovernance #Biotechnology #LifeSciences #Nasdaq #BoardRecruitment

Work arrangement
Yes